Fresenius Medical Care AG & Co. KGAA
|Company Name||Fresenius Medical Care AG & Co. KGAA|
The Firm announces an investigation on behalf of Fresenius Medical Care AG & Co. KGAA (“Fresenius” or the “Company”) (NYSE: FMS) investors concerning the Company and its officers’ possible violations of federal securities laws. GPM is preparing a lawsuit on behalf of Fresenius investors.
Fresenius is a kidney dialysis company that provides dialysis treatment and related dialysis care services, and other health care services.
On January 7, 2017, Fresenius disclosed that it was in receipt of subpoenas from federal prosecutors in connection with the Company’s relationship with the American Kidney Fund, a charity that provides financial aid to patients for kidney dialysis.
On this news, Fresenius stock has fallen as much as 6.70%, to $39.70 during intra-day trading on January 9, 2017.
If you purchased Fresenius securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224 or by email to email@example.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
Submit Your Information
If you suffered a loss on your Fresenius Medical Care AG & Co. KGAA investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.
An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.